Bioventure and Al Razi Partners up With an Exclusive License Agreement for Oncology Product in KSA Market
Bioventure
UAE based biopharmaceutical company focused on biotech and generics commercialization, tech transfer, in/out-licensing
DUBAI, United Arab Emirates and Dammam, Kingdom of Saudi Arabia 2 February 2023 – Bioventure FZ LLC (“Bioventure”) and Al Razi Pharma Industries (“Al Razi") sign an exclusive agreement for the commercialization of an oncology product in Kingdom of Saudi Arabia.
Bioventure, a subsidiary of Yas Holding’s healthcare division GlobalOne Healthcare Holding (GHH), and Al Razi Pharma Industries, a Saudi national pharmaceutical company which is a subsidiary of Saeed Raddad Group (SRG) in Kingdom of Saudi Arabia, has entered into an exclusive license agreement for Pomalidomide.
This partnership grants Al Razi exclusive rights to register and hold marketing authorisation for Pomalidomide, a fully bioequivalent version of Imnovid. Pomalidomide is indicated in the treatment of adult patients with multiple myeloma.
“Alrazi Pharmaceutical Industries -as major part of its Vision- is committed to secure high quality essential pharmaceutical medicinal products to the health care providers and the patients in Saudi Arabia. The Agreement with BioVenture is in alignment with the Kingdom of Saudi Arabia 2030 vision as it shall participate in localizing the Marketing Authorization (MA) and commercialization of one of the latest treatments of Multiple Myeloma.”, said Yasser Ebada, Alrazi General Manager.
“Bioventure is proud to partner with key players in the pharmaceutical and healthcare industries in the Middle East and UAE. Together, we are dedicated to making medicine more accessible to everyone who needs it.”- Ashraf Radwan, CEO of GlobalOne Healthcare Holding
About ALRAZI Pharmaceutical Industries
ALRAZI Pharma Industries is a Saudi national pharmaceutical manufacturer founded in the year 2011 at Dammam, dully registered and licensed under SFDA cGMP/34335, ISO 9001:2015 and ISO 13485:2016.
ALRAZI Pharma Industries is part of SRG (Saeed Raddad Group), which was founded in 1982 and is one of the oldest established independent groups who has a workforce of over 34,000 employees, operating throughout the Kingdom and GCC.
?ALRAZI Pharma Industries represents the vision and contribution of SRG’s owner to serve the Saudi and GCC communities through effective operations in the pharmaceutical sector that enrich the human life and contribute to self-sufficiency of Saudi Arabia of the Pharmaceutical products in alignment with Kingdom vision 2030.?
About Bioventure
Bioventure, a component of the Healthcare Division of Yas Holdings, GlobalOne Healthcare Holding (GHH), focuses on biosimilars and specialised generics, in/out-licensing, tech transfer, and investment in innovative health tech, Medtech, and biotechnology solutions.
领英推荐
Bioventure is the only licensee in the Middle East and Africa for a comprehensive portfolio of biosimilar candidates developed and manufactured by Icelandic biotech company Alvotech. The company is propelled by scientific developments that produce quality healthcare that enhance the consumers’ lives and the healthcare experience.
?Visit?Yas Holding's website?for more information or you can contact:
Bahaa Yousef
Sr. Director-Pricing,
Market Access & Tenders
??: +971502783120
Shreya Jain
Scientific Office Manager
??: +971 (56) 5377166
Managing Director - NAWAH Scientific - Saudia & GCC
2 年Congratulations Dr.Yasser Ebada , Dr.Ali Elbadry, MBA ,B Pharm. & Dr.Bahaa Rashad , All the best into this ambitious great project ??
QA and Compliance Manager | Regulatory Affairs Lead | GMP | Lead Auditor | QMS 9001&13485 | SSGB | | BS Pharmacy | MBA | PMP
2 年Congratulations for AlRazi Pharmaceutical Company and Bioventure for this contract and partnership. Thank you Dr. Ali for your efforts in this regard.
General Manager at AlRazi Pharmaceutical Industries
2 年Potential milestone forward building strategic partnership between two reputable entities and adding value to the patients and healthcare providers in Saudi Arabia in alignment with the kingdom 2030 vision.
Director- Business development
2 年Congratulations!